By Daniel Drachman, MD, as told to Stephanie Watson
Get ready to be amazed by the progress made in treating myasthenia gravis (MG). This article will help you understand the groundbreaking advancements in treatment for this condition.
Let’s take a trip back in time to 1934 when the Scottish doctor Mary Broadfoot Walker, MD, discovered how a simple drug called physostigmine improved muscle function in people with MG. Fast forward to today, and we have treatments like pyridostigmine (Mestinon) to help slow down the breakdown of acetylcholine, which is vital for muscle function.
But that’s not all – we now have even more effective treatments such as plasmapheresis, thymectomy, Monoclonal Antibodies, and a new class of medicine called efgartigimod. These treatments are not just a bandaid solution but offer hope for significant improvement in the quality of life for those living with MG.
Curious to learn more about these extraordinary advances in MG treatment? Click below to read the full article and be prepared to be amazed!